Introduction
Brown tumors (BT) are non-neoplastic, expansive bone lesions that occur only in the setting of hyperparathyroidism. It has been reported in 4.5% of the patients with primary hyperparathyroidism (PHPT) and in 1.5-1.7% of those with secondary hyperparathyroidism (SHPT) [1] . The most usual localization of BT is in mandible, ribs and large bones, are very rare in the spine, and in cervical spine there are few cases reported in literature [2] [3] [4] . To date there are only 11 cases of cervical BT reported globally [2, 5] The aim of this work is to report a 25 year old female with end stage renal failure (ESRF) who developed neck pain without trauma history, finally was determinate the presence of BT in C4 vertebra. This work was reported in line with the SCARE criteria [6] . Laboratory tests at admission: leucocytes 5.50/mcl; hemoglobin 7.4 mg/dL; platelets 190 000/mcl; creatinine 8.57 mg/dL; ureic nitrogen 61 mg/dL; calcium 8.4 mg/dL; phosphorus 5.6 mg/dL; sodium 138 mmol/L; potassium 5.72 mmol/L; chlorine 91 mmol/L.
Case report
The CT scan ( Fig. 1A-C) . showed a lytic lesion on the fourth vertebral body of cervical spine (C4) and a displacement of underlying vertebrae and the posterior elements compromising the cervical canal and displacing the spine. In the magnetic resonance imaging (MRI) we could observe bone erosion of C4 and subluxation of underlying vertebrae with hyperintense images in spinal cord. (Fig. 1D-F) .
It was managed with corpectomy of C4, decompression of cervical canal and the insertion of fixation system and four screws (Fig. 2) . After surgery the patient only developed transitory radicular type pain in C4,C5 territory of the right arm without another symptom.
Microscopic examination showed giant multinucleated cells with bone fragments and intertrabecular fibrosis and cartilage. Giant multinucleated osteoclast type cells mixed with fusiform cells and stroma hemosiderin deposits (Pearls). Ki-67 was positive in less than 1% of cells. (Fig. 3) 
Discussion
The BT also known as osteoclastoma [3] is one of the multiple musculoskeletal complications of hyperparathyroidism secondary to ESRF and specially in patients who are in hemodyalisis. The most frequent localization is in the mandible, the ribs and finally in the large bones. The BT is due to a disorder in the bone resorption and a disorder in the metabolism of PTH and d-vitamin [2] . Cervical BT is extremely rare, with few reported cases globally, the first report was in 1993 [7] and there are only 12 cases reported including this to the date. The importance of the prompt diagnosis of the BT is to establish a multidisciplinary management to prevent progression, neurologic complications and sequelae (radiculopathy, myelopathy) despite its slow progression and a certainly benign behavior. The initial suspicion of this disease must be since the first clinician contact of the patient and with the past medical history of ESRF plus recent neurologic manifestations. The aim of neurosurgical management of these patients is to promote spinal stability and release spinal cord and nerve roots to eliminate risk of neurological deficits [8] . The mainstay in the treatment or prevention of occurrence of a BT is the elimination of the underlying metabolic disorder with parathyroidectomy [8] . We report the case number 12 of cervical BT in the literature. The knowledge about this rare disease is essential to an adequate diagnostic approach and treatment.
